Here are a few of the most interesting Axovant Gene Therapies statistics and facts I was able to dig up. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Please note that some of these numbers are easier to find than others. A few of these Axovant Gene Therapies stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%
Axovant Gene Therapies Facts
- Website: www.axovant.com
- Year Founded: 2014
- Founder: Vivek Ramaswamy
- Headquarters: New York, NY
- CEO: Pavan Cheruvu
Axovant Gene Therapies Statistics
Number of Axovant Gene Therapies employees:
Last updated 6/1/19
Axovant Gene Therapies annual annual net income:
- FY 2019: $129 million net loss
- FY 2018: $221 million net loss
- FY 2017: $180 million net loss
- FY 2016: $133 million net loss
- FY 2015: $21 million net loss